Updates & Insights Blog
This blog features current topics in cancer genomics research and news and updates from OCG. Let's continue the conversation on our Personal Genomics Podcast.
At the present time, all NIH-sponsored meetings are cancelled. We apologize for any inconvenience this may cause and appreciate your understanding.
-
Cindy Kyi, new Health Communications Fellow at the Office of Cancer Genomics (OCG) shares her background, aspirations, and responsibilities as a fellow.
-
Mass cytometry is an antibody-based cost efficient method to measure phenotypes of single cells. CTD2 Network researchers from UCSF describe the workflow for data analysis and applications of mass cytometry in cancer immunology.
-
A study from CGCI's Burkitt Lymphoma Genome Sequencing Project reveals genetic and molecular distinctions between EBV-positive and EBV-negative BL as well as the role that the EBV plays in BL tumorigenesis
-
A key bottleneck in precision oncology is the lack of knowledge of the function of most cancer variants. CTD2 Network researchers discuss cellular profiling methods to assess the functional impact of variants.
-
In HCMI's interactive, searchable online catalog, users can query, view, and download model-associated data. HCMI is developing next-generation cancer models from several cancer types including rare cancers.
-
The Beat AML project integrates molecular, drug response, and clinical data for progress towards individualized therapies for acute myeloid leukemia patients. Dr. Jeffrey Tyner from Oregon Health and Science University describes the collaborative effort.
-
Brain cancers are notoriously hard to study, model, and treat. Dr. Mario Suvà speaks about how single-cell RNA sequencing is helping researchers gain clarity on the origins, development, and response to treatment for these cancers.
-
Dr. Nicholas Navin talks about single-cell DNA sequencing and his research, considerations for working in the single-cell sequencing space, and what’s next for his lab.
-
My name is Eva Tonsing-Carter, and I recently became the Scientific Program Manager for the Human Cancer Models Initiative (HCMI) in the Office of Cancer Genomics (OCG) within the National Cancer Institute (NCI).
-
The success of antiretroviral therapy and prevention education has led to a dramatic decrease in new HIV (human immunodeficiency virus) positive cases in the United States (U.S.) since the 1980s.